|
| Status |
Public on May 22, 2013 |
| Title |
Hepatocellular carcinoma cell line SNU-423 |
| Sample type |
genomic |
| |
|
| Source name |
Hepatocellular carcinoma cell line SNU-423
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: SNU-423
tissue: Liver
disease state: Hepatocellular carcinoma
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
Extraction of genomic DNA was performed the QIAamp DNA mini kit.
|
| Label |
C-Bio and A-DNP
|
| Label protocol |
Samples were processed according to the manufacturers’ instructions (Illumina).
|
| |
|
| Hybridization protocol |
Samples were processed according to the manufacturers’ instructions (Illumina).
|
| Scan protocol |
Samples were processed according to the manufacturers’ instructions (Illumina).
|
| Description |
Genomic DNA was genotyped using Illumina HumanOmni1-Quad BeadChip.
|
| Data processing |
Genomic DNA was genotyped using Infinium HD HumanOmni1-Quad Genotyping BeadChips (Illumina).
|
| |
|
| Submission date |
May 24, 2012 |
| Last update date |
May 22, 2013 |
| Contact name |
Kai Wang |
| Organization name |
Pfizer
|
| Department |
Oncology Research
|
| Street address |
10646 Science Center Dr
|
| City |
San Diego |
| State/province |
CA |
| ZIP/Postal code |
92121 |
| Country |
USA |
| |
|
| Platform ID |
GPL8882 |
| Series (2) |
| GSE38207 |
Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma [cell line] |
| GSE38326 |
Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma |
|
